(Q37374477)

English

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors (English)

1 reference

Europe PubMed Central

20 August 2017

author name string

I Shimon

1

1 reference

Europe PubMed Central

20 August 2017

X Yan

2

1 reference

Europe PubMed Central

20 August 2017

J E Taylor

3

1 reference

Europe PubMed Central

20 August 2017

M H Weiss

4

1 reference

Europe PubMed Central

20 August 2017

M D Culler

5

1 reference

Europe PubMed Central

20 August 2017

S Melmed

6

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

20 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

20 August 2017

100

1 reference

Europe PubMed Central

20 August 2017

2386-2392

1 reference

Europe PubMed Central

20 August 2017

9

1 reference

Europe PubMed Central

20 August 2017

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

6 September 2017

Sandostatin LAR in acromegalic patients: long-term treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

6 September 2017

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

6 September 2017

Somatostatin receptor subtype gene expression in pituitary adenomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

6 September 2017

Somatostatin receptors in human prostate and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

6 September 2017

Surgical management of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

6 September 2017

Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

14 September 2017

Receptor-specific somatostatin analogs: correlations with biological activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

28 September 2017

Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

28 September 2017

Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

26 June 2018

Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

26 June 2018

Resistance to bromocriptine in prolactinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

26 June 2018

Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

26 June 2018

Clonal origin of pituitary adenomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

26 June 2018

Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

2 September 2018

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

2 September 2018

Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

2 September 2018

Somatostatin receptor subtype gene expression in pituitary adenomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

2 October 2018

Human Fetal Adenohypophysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508437

3 December 2018

The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide treatment of acromegaly. A randomized, multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular biology of somatostatin receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/9410919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI119779

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37374477&oldid=1406397730"